Isoptin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 43.2%
Hypertension 13.2%
Product Used For Unknown Indication 10.0%
Atrial Fibrillation 5.8%
Tachycardia 5.8%
Accidental Exposure 2.6%
Asthma 2.1%
Cardiac Disorder 2.1%
Diuretic Therapy 2.1%
Non-obstructive Cardiomyopathy 2.1%
Arrhythmia 1.6%
Cardiac Failure 1.6%
Suicide Attempt 1.6%
Acute Pulmonary Oedema 1.1%
Diabetes Mellitus 1.1%
Heart Rate Irregular 1.1%
Hypercholesterolaemia 1.1%
Neuralgia 1.1%
Arthropathy 0.5%
Atrial Flutter 0.5%
Vomiting 15.6%
Therapeutic Agent Toxicity 8.9%
Renal Failure 6.7%
Suicide Attempt 6.7%
Drug Interaction 4.4%
Dyspnoea 4.4%
Hypertensive Crisis 4.4%
Oedema 4.4%
Orthostatic Hypotension 4.4%
Respiratory Distress 4.4%
Shock 4.4%
Staphylococcal Infection 4.4%
Thrombosis 4.4%
Ureaplasma Infection 4.4%
Ventricular Fibrillation 4.4%
Vision Blurred 4.4%
Accidental Drug Intake By Child 2.2%
Atrioventricular Block 2.2%
Cytolytic Hepatitis 2.2%
Drug Toxicity 2.2%
Secondary
Drug Use For Unknown Indication 16.9%
Product Used For Unknown Indication 12.2%
Hypertension 10.2%
Chronic Obstructive Pulmonary Disease 8.9%
Epilepsy 5.8%
Supraventricular Tachycardia 5.6%
Dermatitis 5.1%
Thrombosis Prophylaxis 5.0%
Tachycardia Paroxysmal 3.8%
Grand Mal Convulsion 3.7%
Rash 3.2%
Drug Exposure During Pregnancy 2.8%
Atrial Fibrillation 2.6%
Essential Hypertension 2.5%
Type 2 Diabetes Mellitus 2.2%
Nausea 2.1%
Conjunctivitis 1.8%
Pruritus 1.8%
Sleep Disorder 1.8%
Vomiting 1.8%
Toxic Epidermal Necrolysis 17.5%
Vomiting 9.1%
Thrombocytopenia 7.1%
Ventricular Fibrillation 6.5%
Oedema 5.2%
Syncope 5.2%
Drug Interaction 4.5%
Haemolytic Anaemia 4.5%
Hypotension 4.5%
Renal Failure 4.5%
Interstitial Lung Disease 3.9%
Somnolence 3.9%
Cytolytic Hepatitis 3.2%
Malaise 3.2%
Renal Failure Acute 3.2%
Tricuspid Valve Disease 3.2%
Hepatitis 2.6%
Hyperkalaemia 2.6%
Hypokalaemia 2.6%
Iron Deficiency Anaemia 2.6%
Concomitant
Drug Use For Unknown Indication 22.6%
Product Used For Unknown Indication 21.9%
Hypertension 12.5%
Atrial Fibrillation 5.1%
Unevaluable Event 4.0%
Rheumatoid Arthritis 3.8%
Chronic Obstructive Pulmonary Disease 3.2%
Osteoporosis 3.2%
Prophylaxis 2.7%
Type 2 Diabetes Mellitus 2.6%
Pain 2.6%
Asthma 2.6%
Non-small Cell Lung Cancer 2.5%
Depression 2.0%
Diabetes Mellitus 2.0%
Gastric Cancer 1.4%
Chronic Lymphocytic Leukaemia 1.4%
Hypercholesterolaemia 1.3%
Intentional Overdose 1.3%
Cardiac Failure 1.2%
Vomiting 14.1%
Renal Failure Acute 10.8%
Thrombocytopenia 10.5%
Respiratory Failure 5.9%
Pyrexia 4.9%
Weight Decreased 4.9%
Renal Failure 4.6%
Dyspnoea 4.2%
Pulmonary Embolism 3.9%
Thrombosis 3.9%
Toxic Epidermal Necrolysis 3.9%
Death 3.6%
Tachycardia 3.6%
Muscle Haemorrhage 3.3%
Sepsis 3.3%
International Normalised Ratio Increased 2.9%
Pain 2.9%
Somnolence 2.9%
Tremor 2.9%
Urinary Tract Infection 2.9%
Interacting
Product Used For Unknown Indication 23.3%
Drug Use For Unknown Indication 14.7%
Atrial Fibrillation 11.0%
Hypertension 9.2%
Atrial Flutter 7.4%
Bronchial Carcinoma 4.9%
Myocardial Infarction 4.9%
Alcoholism 3.7%
Agitation 2.5%
Cardiac Failure 2.5%
Pneumonia Bacterial 2.5%
Restlessness 2.5%
Bronchitis 1.8%
Chronic Obstructive Pulmonary Disease 1.8%
Asthma 1.2%
Hypothyroidism 1.2%
Pancreatic Insufficiency 1.2%
Prostatomegaly 1.2%
Rheumatoid Arthritis 1.2%
Schizoaffective Disorder 1.2%
Drug Interaction 22.5%
Sepsis 10.0%
Hyperkalaemia 7.5%
Malaise 7.5%
Hypotension 5.0%
Respiratory Failure 5.0%
Therapeutic Response Unexpected 5.0%
Thoracic Vertebral Fracture 5.0%
White Blood Cells Urine Positive 5.0%
Atrioventricular Block 2.5%
Cardiogenic Shock 2.5%
Death 2.5%
Drug Therapeutic Incompatibility 2.5%
Hyperglycaemia 2.5%
Hyperthermia 2.5%
Lung Infiltration 2.5%
Orthostatic Hypotension 2.5%
Pallor 2.5%
Renal Failure Acute 2.5%
Shock 2.5%